337 related articles for article (PubMed ID: 19808293)
1. Phosphodiesterase type 5 inhibition: a support of the left ventricular assist device bridge to transplant.
Semigran MJ
Circ Heart Fail; 2008 Nov; 1(4):211-2. PubMed ID: 19808293
[No Abstract] [Full Text] [Related]
2. Phosphodiesterase inhibitors for pulmonary hypertension.
Bergot E; Magnier R; Zalcman G
N Engl J Med; 2010 Feb; 362(6):559; author reply 560. PubMed ID: 20147727
[No Abstract] [Full Text] [Related]
3. Phosphodiesterase inhibitors for pulmonary hypertension.
Galiè N; Rubin LJ; Simonneau G
N Engl J Med; 2010 Feb; 362(6):559-60; author reply 560. PubMed ID: 20175298
[No Abstract] [Full Text] [Related]
4. Preoperative administration of PDE-5 Inhibitors.
Edwards AF; Roy RC
J Clin Anesth; 2009 Mar; 21(2):149; author reply 149-50. PubMed ID: 19329023
[No Abstract] [Full Text] [Related]
5. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.
Archer SL; Michelakis ED
N Engl J Med; 2009 Nov; 361(19):1864-71. PubMed ID: 19890129
[No Abstract] [Full Text] [Related]
6. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension.
Schwartz BG; Kloner RA
Circulation; 2010 Jul; 122(1):88-95. PubMed ID: 20606131
[No Abstract] [Full Text] [Related]
8. Phosphodiesterase type 5 inhibitors in pulmonary hypertension: a Hobson's choice for Indian patients.
Saxena A
Indian Heart J; 2007; 59(4):299-301. PubMed ID: 19126933
[No Abstract] [Full Text] [Related]
9. Cardiac anti-remodelling effects of phosphodiesterase type 5 inhibitors: afterload-(in)dependent?
Kuhn M
Cardiovasc Res; 2009 Apr; 82(1):4-6. PubMed ID: 19221131
[No Abstract] [Full Text] [Related]
10. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
[TBL] [Abstract][Full Text] [Related]
11. Type 5 phosphodiesterase inhibition in heart failure: the next step.
Goldsmith SR
J Am Coll Cardiol; 2007 Nov; 50(22):2145-7. PubMed ID: 18036452
[No Abstract] [Full Text] [Related]
12. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
13. [Use of sildenafil in children with pulmonary arterial hypertension].
He CY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):509-12. PubMed ID: 20540870
[No Abstract] [Full Text] [Related]
14. Pulmonary hypertension and left heart disease: emerging concepts and treatment strategies.
O'Callaghan DS; McNeil K
Int J Clin Pract Suppl; 2008 Jul; (160):29-31. PubMed ID: 18638172
[TBL] [Abstract][Full Text] [Related]
15. [Phosphodiesterase inhibitors in clinical practice. The present and the future. Part II].
Baksheev BI; Kolomiets NM
Klin Med (Mosk); 2007; 85(4):4-11. PubMed ID: 17564028
[TBL] [Abstract][Full Text] [Related]
16. Treating heart failure with sildenafil.
Blum A
Congest Heart Fail; 2009; 15(4):181-5. PubMed ID: 19627292
[TBL] [Abstract][Full Text] [Related]
17. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation.
Hemnes AR; Zaiman A; Champion HC
Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L24-33. PubMed ID: 17965319
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil in Eisenmenger syndrome: safety first.
Wort SJ
Int J Cardiol; 2007 Sep; 120(3):314-6. PubMed ID: 17477991
[No Abstract] [Full Text] [Related]
19. Levitra for sphincter of Oddi dysfunction? Are you kidding?
Affronti J
Gastrointest Endosc; 2009 May; 69(6):1117-9. PubMed ID: 19410043
[No Abstract] [Full Text] [Related]
20. [Pulmonary hypertension in left heart disease].
Opitz CF; Gläser S; Ewert R
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S167-9. PubMed ID: 19718607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
